Watson Names Robert A. Stewart Senior Vice President, Global Operations
Watson Pharmaceuticals announced that Robert A. Stewart has joined the Company in the newly created position of Senior Vice President, Global Operations, effective immediately. In this position, Mr. Stewart will have responsibility for global manufacturing, supply chain, quality and technical operations.
The Company also announced that Thomas R. Russillo, Executive Vice President and President of the Generics Division, has been named Executive Vice President, Global Generics and will head the Company's newly formed Global Generics commercial function. In this position, Mr. Russillo will have overall responsibility for generic sales and marketing for the U.S. and Canada, as well for all international markets that will be added to Watson following completion of the acquisition of the Arrow Group. Both Mr. Stewart and Mr. Russillo report to Paul Bisaro, President and Chief Executive Officer of Watson.
Mr. Stewart joins Watson following an eight year career at Abbott Laboratories, where he most recently served as Divisional Vice President, Global Supply Chain. From 2005 until 2008 he served as Divisional Vice President, Quality Assurance. Prior to this position, Mr. Stewart was Abbott's Divisional Vice President for US/ Puerto Rico and Latin America Plant Operations, as well as Director of Operations for Abbott's Whippany plant. Prior to Abbott, he worked for Knoll Pharmaceutical Company and Hoffman La-Roche Inc.
Mr. Russillo was appointed Executive Vice President and President of the Generics Division in 2006. Prior to joining Watson, he served as a consultant to the Company in connection with the Company's integration planning related to the acquisition of Andrx. From January 2005 until September 2006 Mr. Russillo served as a consultant to various clients in the pharmaceutical industry. From 1990 through 2004, he was President of Ben Venue Laboratories, a division of Boehringer Ingelheim. Prior to Ben Venue, he held a number of senior positions with Baxter International.
Other news from the department people
These products might interest you
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Most read news
More news from our other portals
Last viewed contents
Exact Sciences Obtains Exclusive License to Oncomethylome Sciences' DNA Methylation Biomarkers
Researchers study the human factor in spread of pandemic illness
King's College London, Intercytex and Debra begin Phase II trial with ICX-RHY in patients with severe genetic skin disorder
Adenoid_cystic_carcinoma
Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes
Stronger paper bags, reused repeatedly then recycled for biofuel could be future
Yellow dye solution makes tissue transparent on living animals - "It will completely revolutionize existing optical research in biology"
Integrated DNA Technologies Expands European Production Capabilities - IDT's growth enables faster shipping, broader reach, and expanded European product portfolio
Discovery of a protein linked to metastasis in breast cancer
Mini-fuel cell generates electricity using the body's sugar - Glucose energy source for medicinal implants and sensors
